INHA Research and Development – IRELAND
The following are research and developmental studies in Ireland that the INHA have been and are currently involved in
- Pathfinder Study – Developing a Parental Education Toolkit for Therapeutic Hypothermia following neonatal encephalopathy
- POPART Study – comparing administering surfactant at the back of the throat in addition to CPAP to CPAP alone for the treatment of Respiratory Distress Syndrome
- Studying the underlying mechanisms in neonatal immune metabolic dysregulation and brain injury
- STRIDER Study – RCT of Sildenifil therapy in early onset intra-uterine growth restriction.
- Investigation the diagnostic relevance of the platelet releasate and extracellular vesicles in Pre-Eclampsia
- SafeBoosC Study – comparing the use of cerebral oximetry as measured by near infrared spectroscopy with the standard treatment to reduce cerebral hypoxia during the first 72 hours of extremely preterm infants lives.
- NeoView– studying the use of camera technology in the NICU
- Bright Horizons Newborn Neurodevelopmental Follow-Up
- Neonatal Brain Injury Consortium – the project aims to create a unique national collaborative multidisciplinary research group including parents to optimize the investigation and of management of neonatal brain injury as well as providing joint supervision of the PhD students who will be assigned to each of the 5 projects within this consortium
- Core Outcome Set for GROwth restriction: developing endpoints (COSGROVE) – developing a Core Outcome Set for Fetal Growth Restriction
- PARROT Ireland Trial – Placental growth factor in Assessment of women with suspected pre-eclampsia to Reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial
Follow our LinkedIn page for more details on our ongoing Research and Development roles